ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 11.08
(-8.05%)
CNY 11.08
(-8.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 755.91 Million CNY | -15.79% |
| 2022 | 877.72 Million CNY | 22.06% |
| 2021 | 719.08 Million CNY | 10.29% |
| 2020 | 652.01 Million CNY | 12.16% |
| 2019 | 581.31 Million CNY | 32.79% |
| 2018 | 437.77 Million CNY | 23.11% |
| 2017 | 355.59 Million CNY | 13.89% |
| 2016 | 312.22 Million CNY | 82.74% |
| 2015 | 170.85 Million CNY | 24.76% |
| 2014 | 136.94 Million CNY | -11.08% |
| 2013 | 154.01 Million CNY | 0.57% |
| 2012 | 153.13 Million CNY | -5.49% |
| 2011 | 162.02 Million CNY | 30.67% |
| 2010 | 123.99 Million CNY | 20.92% |
| 2009 | 102.54 Million CNY | 36.04% |
| 2008 | 75.37 Million CNY | 107.62% |
| 2007 | 36.3 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 129.42 Million CNY | -6.41% |
| 2024 Q1 | 138.29 Million CNY | -8.24% |
| 2024 Q3 | 96.25 Million CNY | -25.63% |
| 2023 Q4 | 150.72 Million CNY | -24.74% |
| 2023 FY | 739.14 Million CNY | -15.79% |
| 2023 Q1 | 231.89 Million CNY | 3.04% |
| 2023 Q2 | 199.82 Million CNY | -13.83% |
| 2023 Q3 | 200.26 Million CNY | 0.22% |
| 2022 Q2 | 216.39 Million CNY | 0.54% |
| 2022 Q3 | 221.04 Million CNY | 2.15% |
| 2022 Q4 | 225.06 Million CNY | 1.82% |
| 2022 FY | 877.72 Million CNY | 22.06% |
| 2022 Q1 | 215.22 Million CNY | -9.56% |
| 2021 Q4 | 237.96 Million CNY | 42.14% |
| 2021 FY | 719.08 Million CNY | 10.29% |
| 2021 Q1 | 153.64 Million CNY | 77.43% |
| 2021 Q2 | 160.05 Million CNY | 4.17% |
| 2021 Q3 | 167.41 Million CNY | 4.6% |
| 2020 Q2 | 216.46 Million CNY | 28.64% |
| 2020 Q1 | 168.27 Million CNY | 8.62% |
| 2020 Q3 | 180.68 Million CNY | -16.53% |
| 2020 FY | 652.01 Million CNY | 12.16% |
| 2020 Q4 | 86.59 Million CNY | -52.08% |
| 2019 Q3 | 131.43 Million CNY | -18.1% |
| 2019 FY | 581.31 Million CNY | 32.79% |
| 2019 Q1 | 134.48 Million CNY | 20.89% |
| 2019 Q2 | 160.48 Million CNY | 19.33% |
| 2019 Q4 | 154.91 Million CNY | 17.87% |
| 2018 FY | 437.77 Million CNY | 23.11% |
| 2018 Q4 | 111.25 Million CNY | 9.95% |
| 2018 Q3 | 101.17 Million CNY | -10.45% |
| 2018 Q2 | 112.98 Million CNY | 0.55% |
| 2018 Q1 | 112.36 Million CNY | 79.92% |
| 2017 Q4 | 62.45 Million CNY | -23.88% |
| 2017 Q2 | 118.07 Million CNY | 26.92% |
| 2017 Q1 | 93.02 Million CNY | -7.44% |
| 2017 FY | 355.59 Million CNY | 13.89% |
| 2017 Q3 | 82.04 Million CNY | -30.51% |
| 2016 Q3 | 76.77 Million CNY | 8.04% |
| 2016 FY | 312.22 Million CNY | 82.74% |
| 2016 Q1 | 63.88 Million CNY | 18.6% |
| 2016 Q2 | 71.06 Million CNY | 11.23% |
| 2016 Q4 | 100.5 Million CNY | 30.9% |
| 2015 Q1 | 27.17 Million CNY | -33.37% |
| 2015 FY | 170.85 Million CNY | 24.76% |
| 2015 Q2 | 62.36 Million CNY | 129.49% |
| 2015 Q3 | 27.44 Million CNY | -55.99% |
| 2015 Q4 | 53.86 Million CNY | 96.24% |
| 2014 Q3 | 38.96 Million CNY | 37.2% |
| 2014 Q4 | 40.78 Million CNY | 4.67% |
| 2014 FY | 136.94 Million CNY | -11.08% |
| 2014 Q1 | 28.79 Million CNY | -27.94% |
| 2014 Q2 | 28.4 Million CNY | -1.38% |
| 2013 Q4 | 39.96 Million CNY | 62.96% |
| 2013 Q2 | 47.2 Million CNY | 11.53% |
| 2013 Q1 | 42.32 Million CNY | 34.83% |
| 2013 FY | 154.01 Million CNY | 0.57% |
| 2013 Q3 | 24.52 Million CNY | -48.05% |
| 2012 Q3 | 34.79 Million CNY | -31.04% |
| 2012 Q1 | 36.5 Million CNY | -9.18% |
| 2012 Q4 | 31.39 Million CNY | -9.77% |
| 2012 FY | 153.13 Million CNY | -5.49% |
| 2012 Q2 | 50.45 Million CNY | 38.22% |
| 2011 Q1 | 56.97 Million CNY | 74.66% |
| 2011 FY | 162.02 Million CNY | 30.67% |
| 2011 Q4 | 40.19 Million CNY | 3.12% |
| 2011 Q3 | 38.97 Million CNY | 50.57% |
| 2011 Q2 | 25.88 Million CNY | -54.57% |
| 2010 FY | 123.99 Million CNY | 20.92% |
| 2010 Q2 | 23.73 Million CNY | -42.46% |
| 2010 Q3 | 26.37 Million CNY | 11.11% |
| 2010 Q4 | 32.62 Million CNY | 23.69% |
| 2010 Q1 | 41.25 Million CNY | 70.33% |
| 2009 FY | 102.54 Million CNY | 36.04% |
| 2009 Q3 | 20.03 Million CNY | 0.0% |
| 2009 Q4 | 24.22 Million CNY | 20.88% |
| 2008 FY | 75.37 Million CNY | 107.62% |
| 2007 FY | 36.3 Million CNY | 0.0% |